Lobbying Filing Details

Total Spending

$0

Activities

1

Lobbyists

2

Gov't Entities

0

Filing Information

Filing UUID:: 7ec500d8-ede9-44ba-a5bf-75fce7939c1a
Type:: RR - Registration
Period:: 2025 - 3rd Quarter (July 1 - Sep 30)
Date Posted:: October 01, 2025 at 7:12 PM
Income:: $0
Expenses:: $0
Document URL:: View Submission

Quick Info

Document Type: text/html
Posted By: Randall A. Brater

Registrant

ARENTFOX SCHIFF LLP

Law firm

Washington, District of Columbia

Client

PINNACLE BIOLOGICS, INC.

Developer of complex critical care therapies for cancers

Illinois, United States of America

Lobbying Activities (1)

Activity 1

Medicare/Medicaid

Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product

Lobbyists (2)

DAN RENBERG
BLAKE THELANDER

Foreign Entities (4)

NORDIC CAPITAL LIMITED (PER FUND X)

26 Esplanade JE2 3QA

Contribution: $0

Ownership: 98.88%

ADVANZ PHARMA CORP. LIMITED

Aztec Group House IFC6 The Esplanade JE40QH

Contribution: $0

Ownership: 100.0%

ADVANZ PHARMA HOLDCO LIMITED

Aztec Group House IFC6 The Esplanade JE40QH

Contribution: $0

Ownership: 100.0%

CIDRON AIDA LIMITED

Aztec Group House IFC6 The Esplanade JE40QH

Contribution: $0

Ownership: 98.88%

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.